Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2–p53 complex formation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2–p53 complex formation
Authors
Keywords
-
Journal
JOURNAL OF ANTIBIOTICS
Volume 70, Issue 9, Pages 962-966
Publisher
Springer Nature
Online
2017-06-14
DOI
10.1038/ja.2017.67
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53–MDM2 interaction. Part 1
- (2013) Weisi Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus
- (2013) Elisabetta Caselli et al. JOURNAL OF MEDICAL VIROLOGY
- Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells
- (2013) Simona Dedoni et al. NEUROPHARMACOLOGY
- Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs
- (2013) H. Haruki et al. SCIENCE
- Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents
- (2012) Syed Shoaib Ahmad Shah et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Recruitment of the tumour suppressor protein p73 by Kaposi’s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells
- (2012) S Santag et al. ONCOGENE
- Kaposi’s Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency
- (2012) Eriko Ohsaki et al. Frontiers in Microbiology
- Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
- (2011) Thomas S. Uldrick et al. CANCER LETTERS
- Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
- (2011) Hong Shen et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
- (2011) Arun George Paul et al. PLoS One
- Evidence for Viral Etiology of Multiple Sclerosis
- (2011) Alexandros Tselis SEMINARS IN NEUROLOGY
- KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine
- (2010) Don Ganem JOURNAL OF CLINICAL INVESTIGATION
- Distinct p53, p53:LANA, and LANA Complexes in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas
- (2010) W. Chen et al. JOURNAL OF VIROLOGY
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening
- (2010) Ning Li et al. PLoS One
- Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis
- (2009) Kwun Wah Wen et al. CANCER LETTERS
- Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
- (2009) B. Chandran JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now